Lyme Vaccine
Pfizer is developing a study vaccine (called VLA 15) to protect people against an infectious disease called Lyme borreliosis, also known as Lyme disease. The disease is transmitted by the bite of a tick infected with the Borrelia burgdorferi bacterium. The purpose of this study is to determine the safety and immune response of the VLA15 study vaccine.